Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
A prospective, nonrandomized, open-label, single-arm clinical trial to study efficacy of
rapamycin (sirolimus) in the treatment of Blue Rubber Bleb Nevus Syndrome, hereditary or
sporadic venous malformation
Phase:
Phase 4
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborators:
Air Force General Hospital of the PLA Chinese Academy of Medical Sciences